IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,846,940 | +296.6% | 625,701 | +513.6% | 0.01% | +400.0% |
| Q2 2023 | $717,925 | +95.1% | 101,978 | +69.3% | 0.00% | +100.0% |
| Q1 2023 | $368,011 | -55.9% | 60,231 | -53.9% | 0.00% | -50.0% |
| Q4 2022 | $835,013 | +33.0% | 130,675 | +99.4% | 0.00% | +100.0% |
| Q3 2022 | $628,000 | -52.8% | 65,538 | -45.6% | 0.00% | -50.0% |
| Q2 2022 | $1,331,000 | +7294.4% | 120,522 | +11153.2% | 0.00% | – |
| Q1 2022 | $18,000 | -97.1% | 1,071 | -96.7% | 0.00% | -100.0% |
| Q4 2021 | $629,000 | -84.0% | 32,935 | -79.4% | 0.00% | -75.0% |
| Q3 2021 | $3,939,000 | +787.2% | 159,744 | +1038.2% | 0.00% | +300.0% |
| Q1 2021 | $444,000 | -70.8% | 14,035 | -69.6% | 0.00% | -80.0% |
| Q3 2020 | $1,518,000 | +354.5% | 46,117 | +238.2% | 0.01% | +66.7% |
| Q2 2019 | $334,000 | +145.6% | 13,634 | -11.5% | 0.00% | +200.0% |
| Q4 2018 | $136,000 | +51.1% | 15,403 | +118.6% | 0.00% | 0.0% |
| Q2 2018 | $90,000 | +8900.0% | 7,045 | +5674.6% | 0.00% | – |
| Q3 2017 | $1,000 | -96.8% | 122 | -97.1% | 0.00% | – |
| Q2 2017 | $31,000 | – | 4,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |